Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pain Res ; 16: 1017-1023, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36974308

RESUMEN

Fibromyalgia (FM) is a chronic pain sensitivity syndrome characterized by diffuse musculoskeletal pain and many other systemic manifestations. Low-dose naltrexone (LDN) has been increasingly used as an off-label treatment option in FM. However, current evidence on the safety and efficacy of LDN in patients with FM is not well known. To systematically assess the current evidence on the safety and efficacy of LDN use in the treatment of FM. A comprehensive bibliographic search was conducted on EBM Reviews - Cochrane Central Register of Controlled Trials, EBM Reviews - Cochrane Database of Systematic, Embase, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations, Daily and Versions and Scopus databases in September 2022. Inclusion criteria were articles that were published in English, focusing on clinical trials involving LDN for the treatment of FM. Two reviewers independently screened and extracted the data. A qualitative analysis was used due to the high methodological heterogeneity between studies. The electronic search produced 805 articles. After applying the inclusion criteria, 9 articles (one RCT, two case reports, two case series, and four pilot trials) were selected for evaluation. LDN intervention protocols, study designs, and follow-up periods were different among the included studies. Overall, LDN was found to be effective in the symptomatic management of FM, and of the 78% of included studies that evaluated for safety, no severe adverse events were reported. Proving the efficacy and safety of low-dose naltrexone is a future possibility based on current study data, but the level of scientific evidence is limited. Future well-designed trials with large sample sizes are required.

2.
Glob Adv Health Med ; 10: 21649561211058076, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34925968

RESUMEN

Anxiety is highly reported during the COVID-19 pandemic. The use of acupressure for anxiety is a common practice in integrative medicine, and previous literature has shown that acupressure can be an effective and feasible alternative treatment for decreasing anxiety. Given the social distancing requirements during the COVID-19 pandemic, it appears reasonable to assume that acupressure may be especially suited to treat anxiety under these circumstances. However, there has been relatively little reported use of acupressure for anxiety during the pandemic. This viewpoint aims to highlight the possible role of acupressure as a self-administered therapeutic approach for anxiety amidst the COVID-19 pandemic and to outline key areas for future research.

3.
BMJ Support Palliat Care ; 11(3): 264-270, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33441387

RESUMEN

BACKGROUND: Pain is one of the most common and problematic symptoms encountered by patients with cancer. Due to the multifactorial aetiology, pain management of these patients frequently requires multidisciplinary interventions including conventional support and specialty palliative care. Acupuncture has been identified as a possible adjunctive therapy for symptom management in cancer pain, and there is currently no systematic review focused solely on the evidence of acupuncture on cancer pain in palliative care. OBJECTIVE: To critically analyse currently available publications regarding the use of acupuncture for pain management among patients with cancer in palliative care settings. METHODS: Multiple academic databases were searched from inception to 29 October 2020. Randomised controlled trials involving acupuncture in palliative care for treatment of cancer-related pain were synthesised. Data were extracted by two independent reviewers, and methodological quality of each included study was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) 2011 Levels of Evidence. RESULTS: Five studies (n=189) were included in this systematic review. Results indicated a favourable effect of acupuncture on pain relief in palliative care for patients with cancer. According to OCEBM 2011 Levels of Evidence, they were level 2 in one case (20%), level 3 in two cases (40%) and level 4 in the remaining (40%). Low-level evidence adversely affects the reliability of findings. CONCLUSIONS: Acupuncture may be an effective and safe treatment associated with pain reduction in the palliative care of patients with cancer. Further high-quality, adequately powered studies are needed in the future.


Asunto(s)
Terapia por Acupuntura , Dolor en Cáncer , Neoplasias , Dolor en Cáncer/terapia , Humanos , Neoplasias/complicaciones , Neoplasias/terapia , Manejo del Dolor , Cuidados Paliativos , Reproducibilidad de los Resultados
4.
Explore (NY) ; 14(2): 149-151, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29395572

RESUMEN

Acupuncturists and massage therapists practicing within hospital and clinic settings is a relatively new, but growing phenomenon. Many clinical trials have documented the therapeutic roles these professionals can play in caring for patients. However, to our knowledge, little emphasis has been placed on their ability to aid in the diagnostic process. We report here our experience with these providers playing a critical role in contributing novel diagnostic information, both in the outpatient and inpatient settings. These observations suggest that acupuncturists and massage therapists can play a strategic role in helping achieve timely diagnoses for many patients. Strategies on how to incorporate these professionals into the care flow in the clinic and hospital are discussed.


Asunto(s)
Terapia por Acupuntura , Diagnóstico , Masaje , Adulto , Anciano , Femenino , Hospitales , Humanos , Persona de Mediana Edad , Minnesota
5.
Artículo en Inglés | MEDLINE | ID: mdl-25571353

RESUMEN

This paper presents a screen printed 2.4 GHz antenna and induction charging coil for an active contact lens with a single large pixel user display and on-board 3.8 V 5 uAh rechargeable battery. The antenna traces are printed using silver conductive paste on a 25 um polyethylene terephthalate (PET) substrate. The incoming signal from the antenna feeds into an IC that amplifies and rectifies the signal. The coil provides wireless energy transfer to inductively charge a thin film battery [1] located on the contact lens. The printed antenna achieved a S11 of -4 dB at 2.4 GHz and a gain of -13 dB.


Asunto(s)
Suministros de Energía Eléctrica , Tecnología Inalámbrica/instrumentación , Algoritmos , Transferencia de Energía , Diseño de Equipo , Tereftalatos Polietilenos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA